Changfeng Fu

1.3k total citations
50 papers, 900 citations indexed

About

Changfeng Fu is a scholar working on Pathology and Forensic Medicine, Surgery and Pharmacology. According to data from OpenAlex, Changfeng Fu has authored 50 papers receiving a total of 900 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Pathology and Forensic Medicine, 15 papers in Surgery and 12 papers in Pharmacology. Recurrent topics in Changfeng Fu's work include Spine and Intervertebral Disc Pathology (18 papers), Musculoskeletal pain and rehabilitation (12 papers) and Nerve injury and regeneration (9 papers). Changfeng Fu is often cited by papers focused on Spine and Intervertebral Disc Pathology (18 papers), Musculoskeletal pain and rehabilitation (12 papers) and Nerve injury and regeneration (9 papers). Changfeng Fu collaborates with scholars based in China and United States. Changfeng Fu's co-authors include Hengyi Wang, Jianxun Ding, Yuanliang Xia, Yuehong Li, Xuesi Chen, Bo Shi, Ruohan Yang, Jayesh P. Thawani, Lesan Yan and Hongxia Wang and has published in prestigious journals such as PLoS ONE, Biomaterials and Advanced Functional Materials.

In The Last Decade

Changfeng Fu

50 papers receiving 890 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Changfeng Fu China 18 314 236 205 197 184 50 900
Kan Xu China 17 268 0.9× 332 1.4× 121 0.6× 251 1.3× 213 1.2× 38 1.0k
Shiqing Feng China 20 250 0.8× 143 0.6× 170 0.8× 171 0.9× 575 3.1× 47 1.3k
Zhaojie Wang China 14 308 1.0× 110 0.5× 191 0.9× 256 1.3× 242 1.3× 28 904
Dageng Huang China 17 506 1.6× 495 2.1× 174 0.8× 144 0.7× 202 1.1× 65 1.1k
Xianpeng Huang China 15 423 1.3× 174 0.7× 212 1.0× 109 0.6× 176 1.0× 32 726
Jin Young Hong South Korea 13 216 0.7× 142 0.6× 92 0.4× 88 0.4× 132 0.7× 50 593
Chao Yu China 14 342 1.1× 134 0.6× 146 0.7× 104 0.5× 160 0.9× 33 630
Kaishun Xia China 24 619 2.0× 255 1.1× 279 1.4× 318 1.6× 447 2.4× 50 1.5k
Hongfei Xiang China 19 238 0.8× 210 0.9× 77 0.4× 215 1.1× 280 1.5× 76 979
Jingkai Wang China 21 624 2.0× 358 1.5× 284 1.4× 399 2.0× 326 1.8× 45 1.5k

Countries citing papers authored by Changfeng Fu

Since Specialization
Citations

This map shows the geographic impact of Changfeng Fu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Changfeng Fu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Changfeng Fu more than expected).

Fields of papers citing papers by Changfeng Fu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Changfeng Fu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Changfeng Fu. The network helps show where Changfeng Fu may publish in the future.

Co-authorship network of co-authors of Changfeng Fu

This figure shows the co-authorship network connecting the top 25 collaborators of Changfeng Fu. A scholar is included among the top collaborators of Changfeng Fu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Changfeng Fu. Changfeng Fu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Yuehong, et al.. (2025). Biomaterial-based treatments for structural reconstruction in intervertebral disc degeneration. Biomaterials. 324. 123426–123426. 3 indexed citations
3.
Fan, Jiawei, et al.. (2023). Potential targets and applications of nanodrug targeting myeloid cells in osteosarcoma for the enhancement of immunotherapy. Frontiers in Pharmacology. 14. 1271321–1271321. 6 indexed citations
4.
Li, Zhuohan, et al.. (2023). Biomaterial scaffolds regulate macrophage activity to accelerate bone regeneration. Frontiers in Bioengineering and Biotechnology. 11. 1140393–1140393. 16 indexed citations
5.
Fan, Jiawei, et al.. (2023). Potential therapeutic targets of macrophages in inhibiting immune damage and fibrotic processes in musculoskeletal diseases. Frontiers in Immunology. 14. 1219487–1219487. 18 indexed citations
6.
Liu, Haiyan, et al.. (2023). Natural products can modulate inflammation in intervertebral disc degeneration. Frontiers in Pharmacology. 14. 1150835–1150835. 8 indexed citations
7.
Xia, Yuanliang, et al.. (2023). Biomaterials delivery strategies to repair degenerated intervertebral discs by regulating the inflammatory microenvironment. Frontiers in Immunology. 14. 1051606–1051606. 17 indexed citations
8.
Xia, Yuanliang, et al.. (2023). Mesenchymal stem cells in the treatment of spinal cord injury: Mechanisms, current advances and future challenges. Frontiers in Immunology. 14. 1141601–1141601. 51 indexed citations
9.
Wu, Guangzhi, et al.. (2022). Application of stem cells combined with biomaterial in the treatment of intervertebral disc degeneration. Frontiers in Bioengineering and Biotechnology. 10. 1077028–1077028. 6 indexed citations
10.
Xia, Yuanliang, et al.. (2022). Application of mesenchymal stem cell-derived exosomes from different sources in intervertebral disc degeneration. Frontiers in Bioengineering and Biotechnology. 10. 1019437–1019437. 39 indexed citations
11.
Wang, Hengyi, et al.. (2022). Reverse Adverse Immune Microenvironments by Biomaterials Enhance the Repair of Spinal Cord Injury. Frontiers in Bioengineering and Biotechnology. 10. 812340–812340. 13 indexed citations
12.
Li, Jie, et al.. (2021). Physical Cues of Matrices Reeducate Nerve Cells. Frontiers in Cell and Developmental Biology. 9. 731170–731170. 7 indexed citations
13.
Li, Jie, et al.. (2020). Implantable and Injectable Biomaterial Scaffolds for Cancer Immunotherapy. Frontiers in Bioengineering and Biotechnology. 8. 612950–612950. 45 indexed citations
14.
Shi, Bo, Jianxun Ding, Lesan Yan, et al.. (2019). Polymer scaffolds facilitate spinal cord injury repair. Acta Biomaterialia. 88. 57–77. 128 indexed citations
15.
Ma, Hongyun, Weiqian Jiang, Jianxun Ding, et al.. (2016). Polymer Nanoparticle-Based Chemotherapy for Spinal Malignancies. Journal of Nanomaterials. 2016. 1–14. 5 indexed citations
16.
Wang, Zheng, Changfeng Fu, Feng Xu, et al.. (2016). Interleukin 1 Polymorphisms Contribute to Intervertebral Disc Degeneration Risk: A Meta-Analysis. PLoS ONE. 11(6). e0156412–e0156412. 16 indexed citations
17.
Gao, Feng, Yadong Liu, Xinming Zhuang, et al.. (2016). Bioinformatics analysis of molecular mechanisms involved in intervertebral disc degeneration induced by TNF-α and IL-1β. Molecular Medicine Reports. 13(3). 2925–2931. 13 indexed citations
18.
Miao, Weiwei, Qi Zhang, Zhenyu Wang, et al.. (2013). Analysis of crucial molecules involved in herniated discs and degenerative disc disease. Clinics. 68(2). 225–229. 2 indexed citations
19.
Wang, Zhenyu, et al.. (2012). Penetrating Injury of the Spinal Cord Treated Surgically. Orthopedics. 35(7). e1136–40. 7 indexed citations
20.
Luo, Yang, Changfeng Fu, Zhenyu Wang, et al.. (2012). Asiaticoside attenuates the effects of spinal cord injury through antioxidant and anti-inflammatory effects, and inhibition of the p38-MAPK mechanism. Molecular Medicine Reports. 12(6). 8294–8300. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026